157 related articles for article (PubMed ID: 9421349)
1. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Whitehouse RM; Talbot DC; Gatter KC; Harris AL
Int J Cancer; 1997 Dec; 74(6):565-70. PubMed ID: 9421349
[TBL] [Abstract][Full Text] [Related]
2. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
Giatromanolaki A; Koukourakis MI; O'Byrne K; Kaklamanis L; Dicoglou C; Trichia E; Whitehouse R; Harris AL; Gatter KC
Anticancer Res; 1996; 16(6B):3819-25. PubMed ID: 9042264
[TBL] [Abstract][Full Text] [Related]
6. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
9. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
[TBL] [Abstract][Full Text] [Related]
10. Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma.
Fontanini G; Boldrini L; Vignati S; Chinè S; Basolo F; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Eur J Cancer; 1998 Apr; 34(5):718-23. PubMed ID: 9713280
[TBL] [Abstract][Full Text] [Related]
11. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.
Grossi F; Loprevite M; Chiaramondia M; Ceppa P; Pera C; Ratto GB; Serrano J; Ferrara GB; Costa R; Boni L; Ardizzoni A
Eur J Cancer; 2003 Jun; 39(9):1242-50. PubMed ID: 12763212
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer.
Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH
Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma.
O'Neill AJ; Staunton MJ; Gaffney EF
Histopathology; 1996 Jul; 29(1):45-50. PubMed ID: 8818693
[TBL] [Abstract][Full Text] [Related]
18. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
Cox G; Louise Jones J; Andi A; Abrams KR; O'Byrne KJ
Lung Cancer; 2001 Dec; 34(3):417-26. PubMed ID: 11714539
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
